{"id":1037,"date":"2020-01-04T14:32:00","date_gmt":"2020-01-04T14:32:00","guid":{"rendered":"https:\/\/quantadt.wpengine.com\/us\/?p=1037"},"modified":"2023-09-21T16:29:38","modified_gmt":"2023-09-21T16:29:38","slug":"quanta-to-present-at-the-40th-annual-dialysis-conference","status":"publish","type":"post","link":"https:\/\/quantadt.com\/us\/quanta-to-present-at-the-40th-annual-dialysis-conference\/","title":{"rendered":"Quanta to Present at the 40th Annual Dialysis Conference"},"content":{"rendered":"\n<p><strong>4 January 2020<\/strong>: Quanta Dialysis Technologies Ltd, a British med-tech company that has developed SC+, a personal haemodialysis (HD) system, today announces that the Company will be presenting at the 40th Annual Dialysis Conference (ADC), which runs from 8 to 11 February 2020, at the Kansas City Convention Center, Missouri, USA.<\/p>\n\n\n\n<p>In addition, Quanta announces it has filed a 510(k) submission with the FDA for SC+, with a follow-up study planned to then extend use to Home HD. John E. Milad, Chief Executive Officer of Quanta, said: \u201cWe are delighted to be working with leading US Home HD experts on this<br>important study that will help us to bring SC+ to American patients and healthcare professionals. SC+ has been designed to make home dialysis accessible to more patients, supporting the objectives of the Advancing American Kidney Health Initiative.\u201d<\/p>\n\n\n\n<p>Dr. Paul Komenda, Chief Medical Officer, will provide an update on SC+, explaining how it will enable choice, efficiency and empowerment to both patients and physicians in the \u201cHome Dialysis Machines\u201d session on Monday, 10 February at 2:00pm.<\/p>\n\n\n\n<p>The presentation will be followed by a device demonstration at 4:15pm.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Full details of the session are as follows<\/h3>\n\n\n\n<p><strong>Session<\/strong>: Home Dialysis Machines<br><strong>Date<\/strong>: Monday 10 February<br><strong>Time<\/strong>: 2:00pm<\/p>\n\n\n\n<p>Quanta will also be presenting a poster at ADC, reporting on the annual therapy cost of dialysis when using SC+ in Canada. The results demonstrate the feasibility of cost-saving when using a small and easy-to-use haemodialysis system like SC+ on an every-other day treatment regimen.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Full details of the poster presentation are as follows<\/h3>\n\n\n\n<p><strong>Title<\/strong>: Annual Therapy Cost of Dialysis with the Quanta SC+ Personal Haemodialysis System<br><strong>Location<\/strong>: Home Dialysis<br><strong>First Presentation<\/strong>: Sunday 9 February between 1:00pm \u2013 2:00pm<br><strong>Second Presentation<\/strong>: Monday 10 February between 1:00pm \u2013 2:00pm<\/p>\n\n\n\n<p>If you would like to arrange a meeting with John E. Milad, Chief Executive Officer, or Paul Komenda, Chief Medical Officer, at the conference, please contact <a href=\"mailto:enquiries@quantadt.com\">enquiries@quantadt.com<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>4 January 2020: Quanta Dialysis Technologies Ltd, a British med-tech company that has developed SC+, a personal haemodialysis (HD) system, today announces that the Company will be presenting at the 40th Annual Dialysis Conference (ADC), which runs from 8 to 11 February 2020, at the Kansas City Convention Center, Missouri, USA. In addition, Quanta announces [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1013,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","footnotes":""},"categories":[7],"tags":[],"class_list":["post-1037","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles"],"acf":[],"_links":{"self":[{"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/posts\/1037","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/comments?post=1037"}],"version-history":[{"count":0,"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/posts\/1037\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/media\/1013"}],"wp:attachment":[{"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/media?parent=1037"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/categories?post=1037"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/tags?post=1037"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}